Association of ocular adverse events with varenicline solution use: a population-based study
Sign Up to like & getrecommendations! Published in 2025 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2025.2460454
Abstract: ABSTRACT Background Approved by the FDA in 2021, varenicline solution is the first nasal spray specifically designed to enhance basal tear film production for treating dry eye disease (DED). However, there is a lack of… read more here.
Keywords: ocular adverse; adverse events; use; varenicline solution ... See more keywords
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye disease.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2022.22208
Abstract: BACKGROUND: Matching-adjusted indirect comparison (MAIC) is a methodology for cross-study comparisons after adjusting for baseline characteristic imbalances. It is a comparative analytical approach used across therapeutic areas absent head-to-head trial outcomes. OBJECTIVE: To compare the… read more here.
Keywords: varenicline solution; trial; phase; solution ... See more keywords